Five Star Equities Provides Stock Research on Cytokinetics and Galectin Therapeutics
Continue ReadingTag: five-star-equities
FDA on Pace to Approve More New Drugs in 2012 Than the 30 Approved in 2011
Five Star Equities Provides Stock Research on CytRx and ZIOPHARM Oncology
Continue Reading
Guidelines of New “Stress Tests” Announced – Focused on the Handling of Major Recessions in China and Europe
Five Star Equities Provides Stock Research on U.S. Bancorp and Hudson City Bancorp
Continue Reading
Biotech Industry Experiencing a Higher Amount of FDA New Drug Approvals in 2012
Five Star Equities Provides Stock Research on Discovery Laboratories and Cardium Therapeutics
Continue Reading
Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry-s Success in 2012
Five Star Equities Provides Stock Research on Ariad Pharmaceuticals and AVEO Pharmaceuticals
Continue Reading
Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry-s Success in 2012
Five Star Equities Provides Stock Research on Amgen and Regeneron Pharmaceuticals
Continue Reading
Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases
Five Star Equities Provides Stock Research on Orexigen Therapeutics and PDL BioPharma
Continue Reading
Increased Iron Ore Demand From China in the Fourth Quarter to Help Ease Shipping Industry-s Oversupply
Five Star Equities Provides Stock Research on Navios Maritime and Overseas Shipholding Group
Continue Reading
FDA on Pace to Approve More New Drugs in 2012 Than the 30 Approved in 2011
Five Star Equities Provides Stock Research on Astex Pharmaceuticals and Amicus Therapeutics
Continue Reading
Arena Pharmaceuticals and VIVUS Look to Benefit as Aetna Provides Coverage for Anti-Obesity Drugs
Five Star Equities Provides Stock Research on Arena Pharmaceuticals and VIVUS
Continue Reading